Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead

Enrico Fabris, Serge Korjian, Barry S. Coller, Jurrien M. Ten Berg, Christopher B. Granger, C. Michael Gibson, Arnoud W. J. van 't Hof*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Number of pages12
JournalThrombosis and Haemostasis
DOIs
Publication statusE-pub ahead of print - 7 Mar 2021

Keywords

  • (12)
  • IIIa
  • P2Y
  • RUC-4
  • STEMI
  • antiplatelet therapy
  • coronary reperfusion
  • glycoprotein IIb
  • inhibitors
  • myocardial infarction
  • pre-hospital
  • selatogrel
  • PLATELET-AGGREGATION
  • IIB-IIIA INHIBITORS
  • CLOPIDOGREL PRETREATMENT
  • PRIMARY PCI
  • EMERGENCY-DEPARTMENT
  • TASK-FORCE
  • DOUBLE-BLIND
  • ST-SEGMENT ELEVATION
  • ELEVATION MYOCARDIAL-INFARCTION
  • PRIMARY ANGIOPLASTY

Cite this